EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Exploring the Benefits of Bioassay in Pharmacology
Pharmacology the study of drugs and their effects on living organisms is a multifaceted field crucial to the development and improvement of pharmaceuticals Bioassay a method that assesses the potency of substances
Trustworthy AI in Drug Discovery: From Innovation to Regulatory Readiness
Artificial intelligence is entering a new phase in drug discovery After years of enthusiasm for predictive models generative chemistry and automated screening attention is shifting from what AI can generate to whether its outputs can be trusted
The Next Growth Strategy: Scaling GLP-1 Manufacturing and Global Market Expansion
For most of the past four years the strategic conversation around GLP receptor agonists was a demand story Prescriptions outran forecasts waiting lists formed pharmacy shelves emptied and the commercial debate centred on reimbursement prescriber behaviour and how far the obesity indication could stretch That conversation has changed Demand for incretin therapies is now the most predictable variabl...
Top 5 Pharma Content Formats That Drive Engagement and Leads
The pharmaceutical business is experiencing a significant change in the way it informs the healthcare professionals decisionmakers and business partners Conventional means of promotion is no longer sufficient in a context whereby buyers do a lot of research before involving themselves with vendors Consequently pharma content marketing has turned out to be a vital instrument of establishing credibi...
How Drug Patents Shape the Competitive Landscape in Pharma?
It can rightly be said that the business of pharmaceuticals is very sensitive and crucial since business is all about the manufacturing of change for the purpose of ridding the world of diseases
Data Security Challenges in Pharma IT: Safeguarding Sensitive Information
The pharmaceutical industry faces several data security challenges in its IT infrastructure primarily related to safeguarding sensitive information The nature of the data regulatory requirements and the increasing sophistication of cyber threats
-
Techno Trends
University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment
Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine a novel antimalarial compound being developed as a potential singledose treatment for malaria
-
Projects
Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility
Genentech a member of the Roche Group plans to invest approximately US million in a new device fillfinish manufacturing facility at its acre campus in Hillsboro Oregon The project will add endtoend manufacturing
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Trustworthy AI in Drug Discovery: From Innovation to Regulatory Readiness
Antonio Lavecchia
This article examines how AI-driven drug discovery is moving from experimental innovation toward trustworthy, regulatory-ready implementation. It discusses validation, interpretability, data integrity...
-
2
The Next Growth Strategy: Scaling GLP-1 Manufacturing and Global Market Expansion
Lakshmi
Incretin medicines have moved from a supply crisis into a scale contest. For European pharmaceutical and biotech leaders, growth in this class now rests on industrial decisions: synthesis route, purif...
-
3
Top 5 Pharma Content Formats That Drive Engagement and Leads
Kate Williamson
Strategic content is becoming more popular among pharmaceutical companies as a tool to meet the need of healthcare professionals and produce qualified leads. This paper discusses the top five pharma c...
-
4
How Drug Patents Shape the Competitive Landscape in Pharma?
Kate Williamson
Drug patents are central in the pharmaceutical field because they offer marketing privileges over drugs, foster technological advancement, and control the market. They drive the research expenditure,...
-
5
Data Security Challenges in Pharma IT: Safeguarding Sensitive Information
Kate Williamson
The pharmaceutical sector encounters intricate data security challenges in its IT setup, encompassing data sensitivity, regulatory compliance, cybersecurity threats, supply chain risks, and insider th...
press releases Read more...
BioLife receives US patent for novel effervescent tablet technology for oral peptide delivery
BioLife announced today that the US Patent and Trademark Office has granted US Patent B for its novel oral peptide delivery technology via effervescent tablets It was developed for current and future peptide therapies for obesity diabetes and metabolic disorders
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
Prelude Therapeutics Incorporated Nasdaq PRLD a precision oncology company today announced that the US Food and Drug Administration FDA cleared the Company to proceed with a Phase study under
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
Electra Therapeutics a clinicalstage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immunemediated diseases and cancer today announced
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
Insilico Medicine Insilico HKEX a clinicalstage biotechnology company powered by generative AI today announced that it has dosed the first patient with Rentosertib known as ISM INS
Events Read more...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWS Read more...
Renova Pharmaceuticals Launches First Three US Generic Products
Renova Pharmaceuticals has launched its first three generic products in the US marking a major milestone as the company moves from developing its product and regulatory pipeline to establishing a commercial presence in the US generics market
Community Clinical Research Joins PhaseWell Research to Expand CNS Clinical Trial Access in Te
PhaseWell Research has partnered with Community Clinical Research CCR in Austin Texas to strengthen its inpatient central nervous system CNS research capabilities and expand access to clinical trials across Texas
Sysmex Europe and Cytek Biosciences collaborate to expand access to advanced clinical flow cytometry
Sysmex Europe SE and Cytek Biosciences Inc have announced a strategic collaboration across more than a dozen European countries to improve clinical flow cytometry workflows and expand access to advanced diagnostic solutions
Ratio Therapeutics and RayzeBio enter collaboration to advance novel radiopharmaceutical programme
Ratio Therapeutics Inc has entered into a research collaboration and licence agreement with RayzeBio Inc to advance a new radiopharmaceutical programme focused on two undisclosed targets
HCW Biologics Signs Exclusive Distribution Agreement with Akron Biotech for HCW11-006
HCW Biologics Inc a USbased clinicalstage biopharmaceutical company has entered into an exclusive distribution agreement with Akron Biotech to commercialise HCW as a reagent for producing highly functional human CART cells
Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement
Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology






